Skip to main content

Incannex welcomes world-leading psychedelics experts to advisory board

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incannex Healthcare Ltd (ASX:IHL, NASDAQ: IXHL) director Peter Widdows tells Proactive the company has appointed three world-renowned psychedelic therapy and science experts to its Clarion Clinics Group Advisory Board. The Clarion Clinics Groups Pty Ltd is a collaborative venture between Incannex and three leading Australian psychedelics experts - Dr Paul Liknaitzky, Professor Suresh Sundram and Sean O’Carroll.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

Jonathan@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  262.90
-2.11 (-0.80%)
AAPL  301.68
-0.57 (-0.19%)
AMD  432.31
-15.27 (-3.41%)
BAC  51.19
-0.04 (-0.09%)
GOOG  381.63
-3.27 (-0.85%)
META  597.62
-7.44 (-1.23%)
MSFT  416.46
-4.60 (-1.09%)
NVDA  218.76
-4.71 (-2.11%)
ORCL  187.33
-0.83 (-0.44%)
TSLA  415.45
-1.81 (-0.43%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.